An Australian state’s ambition to be the nation's “medical cannabis capital” is unlikely to succeed unless market access for local patients substantially improves, experts note. Patient access to medical cannabis remains a serious concern despite marked improvements...
Matt Lamers
Matt Lamers's Latest Posts
Big Pharma ‘missing link’ in Canada’s emerging marijuana industry
The entrance of multinational pharmaceutical companies into Canada’s cannabis sector will mark one of the next major themes in the industry, analysts told Marijuana Business Daily.
What cannabis shortage? Canada has ‘sufficient supply,’ Ottawa says
Canada’s federal government says the country has more than enough legal cannabis to meet demand even as some provinces complain about shortages. “The data is clear: There remains sufficient supply to meet and exceed existing demand,” Bill Blair, Canada's minister in...
In race to win Europe, Aurora Cannabis and other Canadian companies pursue EU-GMP
In an effort to add to their international credibility and gain leverage over competitors, more Canadian medical marijuana firms are aiming to achieve one of the highest levels of quality certification in the world.
In unusual move, Thailand to revoke foreign patent requests on marijuana
Thailand’s military government ordered the Department of Intellectual Property (DIP) to revoke within three months foreign companies’ patent applications that include cannabis.
Ontario Cannabis Store offers opportunities for delivery, insurance firms
(This story has been updated with the application deadline for transportation and delivery services. - Ed.) The Ontario Cannabis Store (OCS) is looking to expand its network of partners, including for same-day deliveries and risk management services. Adding same-day...
Half of Canada’s cannabis cultivation applicants in limbo
More than half of the cannabis site applications in Canada had not transitioned to the new licensing system as of the end of 2018, meaning their applications are effectively in regulatory limbo and not being scrutinized by the country’s cannabis regulator. Only 409 of...
Davos report: Europe could be world’s largest medical marijuana market in 5 years
Europe’s three largest medical cannabis markets could double in size in 2019, making this a “transformative” year for the European market, according to a new report by United Kingdom-based analytics firm Prohibition Partners, launched alongside the Davos World...
‘Reckoning’ coming: Licensed cannabis cultivators, applicants near 1,000 in Canada
More companies than ever are lining up to be licensed cannabis cultivators in Canada despite an increasingly competitive market outlook, according to new data from the country’s regulatory body for cannabis producers. As of Dec. 31, 2018, almost 840 site applications...
Philippines medical cannabis bill advances, but it’s not law yet
A bill to legalize and regulate medical cannabis in the Philippines was approved in the House, but steps remain before it can become law.
British Columbia, Ontario at bottom of per-person legal cannabis sales
Provinces with more physical cannabis stores saw significantly higher per-person sales in the six weeks after Canada's legalization of recreational marijuana, according to new data from Statistics Canada - an indication that consumers have a strong preference to buy...
Class action lawsuit against cannabis firm Organigram will proceed to trial in Nova Scotia
A class action lawsuit targeting Canadian licensed medical marijuana grower Organigram has been approved to proceed to trial by the Nova Scotia Supreme Court. The suit stems from product recalls that took place between Dec. 28, 2016, and Jan. 9, 2017, in which...













